Literature DB >> 22678384

Biomarker patents for diagnostics: problem or solution?

Michael M Hopkins1, Stuart Hogarth.   

Abstract

Mesh：

Substances：

Year:  2012        PMID： 22678384     DOI： 10.1038/nbt.2257

Source DB:  PubMed          Journal:  Nat Biotechnol        ISSN： 1087-0156            Impact factor:   54.908


× No keyword cloud information.
  13 in total

1.  Effects of patents and licenses on the provision of clinical genetic testing services.

Authors:  Mildred K Cho; Samantha Illangasekare; Meredith A Weaver; Debra G B Leonard; Jon F Merz
Journal:  J Mol Diagn       Date:  2003-02       Impact factor: 5.568

Review 2.  A molecular monopoly? HPV testing, the Pap smear and the molecularisation of cervical cancer screening in the USA.

Authors:  Stuart Hogarth; Michael M Hopkins; Victor Rodriguez
Journal:  Sociol Health Illn       Date:  2011-11-25

3.  Putting pharmacogenetics into practice.

Authors:  Michael M Hopkins; Dolores Ibarreta; Sibylle Gaisser; Christien M Enzing; Jim Ryan; Paul A Martin; Graham Lewis; Symone Detmar; M Elske van den Akker-van Marle; Adam M Hedgecoe; Paul Nightingale; Marieke Dreiling; K Juliane Hartig; Wieneke Vullings; Tony Forde
Journal:  Nat Biotechnol       Date:  2006-04       Impact factor: 54.908

Review 4.  New-wave diagnostics.

Authors:  Monya Baker
Journal:  Nat Biotechnol       Date:  2006-08       Impact factor: 54.908

5.  Linking pharmacogenetics-based diagnostics and drugs for personalized medicine.

Authors:  Louis P Garrison; M J Finley Austin
Journal:  Health Aff (Millwood)       Date:  2006 Sep-Oct       Impact factor: 6.301

6.  The phantom menace of gene patents.

Authors:  Sibylle Gaisser; Michael M Hopkins; Kathleen Liddell; Eleni Zika; Dolores Ibarreta
Journal:  Nature       Date:  2009-03-26       Impact factor: 49.962

7.  Legal uncertainty in the area of genetic diagnostic testing.

Authors:  Isabelle Huys; Nele Berthels; Gert Matthijs; Geertrui Van Overwalle
Journal:  Nat Biotechnol       Date:  2009-10       Impact factor: 54.908

8.  Overhauling the reimbursement system for molecular diagnostics.

Authors:  Nafees N Malik
Journal:  Nat Biotechnol       Date:  2011-05       Impact factor: 54.908

9.  Medical device recalls and transparency in the UK.

Authors:  Matthew Thompson; Carl Heneghan; Matthew Billingsley; Deborah Cohen
Journal:  BMJ       Date:  2011-05-13

10.  DNA patents and diagnostics: not a pretty picture.

Authors:  Julia Carbone; E Richard Gold; Bhaven Sampat; Subhashini Chandrasekharan; Lori Knowles; Misha Angrist; Robert Cook-Deegan
Journal:  Nat Biotechnol       Date:  2010-08       Impact factor: 54.908
View more
  3 in total

1.  The European BRCA patent oppositions and appeals: coloring inside the lines.

Authors:  Gert Matthijs; Isabelle Huys; Geertrui Van Overwalle; Dominique Stoppa-Lyonnet
Journal:  Nat Biotechnol       Date:  2013-08       Impact factor: 54.908

Review 2.  Microfluidic Exosome Analysis toward Liquid Biopsy for Cancer.

Authors:  Mei He; Yong Zeng
Journal:  J Lab Autom       Date:  2016-05-23

Review 3.  DNA Methylation Cancer Biomarkers: Translation to the Clinic.

Authors:  Warwick J Locke; Dominic Guanzon; Chenkai Ma; Yi Jin Liew; Konsta R Duesing; Kim Y C Fung; Jason P Ross
Journal:  Front Genet       Date:  2019-11-14       Impact factor: 4.599
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.